Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study

Scars Clinical Trial

— RAVNAS  

Official title:

Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study (RAVNAS)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01932359
• Other study ID #: H13-01961
• Status: Completed
• Phase: N/A
• First received: August 27, 2013
• Last updated: April 10, 2015
• Start date: October 2013
• Est. completion date: November 2014

Study information

• Verified date: April 2015
• Source: University of British Columbia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Interventional

Clinical Trial Summary

This study aims to compare scar outcomes between rapidly absorbable and non-absorbable sutures (stitches) for the closure of wounds after skin cancer removal on the face.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 105
• Est. completion date: November 2014
• Est. primary completion date: March 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Mohs surgical wound on the face

• Wound greater than or equal to 4 cm in length

• Subject is willing and capable of cooperating to the extent and degree required by the protocol and will be able to come for follow-up assessments

• Subject has read and signed Subject Information and Informed Consent Form

Exclusion Criteria:

• Surgical wound less than 4 cm in length

• Surgical site outside of face

• Subject to be be treated with radiation therapy after surgery

• Subject is not willing or able to attend for follow-up assessments

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Scars

Intervention

Other:
• rapidly absorbable suture (Vicryl Rapide)

• non-absorbable suture (Ethilon)

Locations

Country	Name	City	State
Canada	Department of Dermatology and Skin Science, UBC, Vancouver General Hospital	Vancouver	British Columbia

Sponsors (1)

Lead Sponsor	Collaborator
University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Stony Brook Scar Evaluation Scale (SBSES) score		6 months	No